Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00200759 · ClinicalTrials.gov registry record · Phase 1
Drug Interactions and Bioavailability of Cranberry
A Phase 1 study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- Phase 1
- Development phase
- 16
- Enrollment target
NCT00200759 is a Phase 1 study that has completed, run by Medical University of South Carolina. The registered enrollment target is 16 participants.
The verdict
NCT00200759, a Phase 1 study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 16 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the potential of cranberry juice to interact with conventional drugs. This study will also determine the the amount of cranberry flavonoids that appear in the blood and in the urine.
Interventions
- DRUG Cranberry juice and capsules
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2004-10 |
| Est. Completion | 2007-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00200759
The ClinicalTrials.gov registry entry for NCT00200759 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cranberry juice and capsules is the first listed.
NCT00200759 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00200759 about?
NCT00200759 is a clinical study titled "Drug Interactions and Bioavailability of Cranberry". The purpose of this study is to evaluate the potential of cranberry juice to interact with conventional drugs. This study will also determine the the amount of cranberry flavonoids that appear in the blood and in the urine.
What is the current status of trial NCT00200759?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 16 participants. The study started on 2004-10. Estimated completion is 2007-12.
What interventions are being tested in trial NCT00200759?
The interventions under investigation include: Cranberry juice and capsules (DRUG).
Who is sponsoring clinical trial NCT00200759?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.